| Features: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Rutin, a Quercetin Glycoside Rutin, a natural flavonoid glycoside found in many plants like buckwheat, citrus fruits, and apples, has shown promising neuroprotective and anticancer properties. Rutin is a flavonoid glycoside composed of quercetin bound to the disaccharide rutinose. It is widely found in buckwheat, citrus fruits, apples, and tea. In cancer models, rutin exhibits antioxidant, anti-inflammatory, anti-proliferative, and pro-apoptotic effects. Because it is glycosylated, rutin itself has relatively low cellular permeability; many biological effects are mediated after intestinal hydrolysis to quercetin and subsequent phase-II metabolites. Mechanistically, rutin is most consistently associated with suppression of NF-κB and PI3K/AKT signaling, modulation of MAPK pathways, redox regulation (Nrf2/ROS balance), inhibition of angiogenesis (VEGF), and induction of cell-cycle arrest and apoptosis in preclinical systems. Effects are model-dependent and often concentration-dependent, with antioxidant behavior dominating in normal tissue contexts and context-dependent pro-oxidant effects described in some tumor settings. -Scavenges free radicals, reduces oxidative stress -Inhibits pro-inflammatory cytokines like IL-1β, TNF-α, and reduces activation of NF-κB. -Inhibition of Aβ Aggregation (AD) -Mild inhibitory effects on acetylcholinesterase (AChE), helping enhance cholinergic function. -May upregulate BDNF expression Cancer: -Induces cell cycle arrest in G2/M phase. -Inhibits VEGF, Suppresses MMP-2 and MMP-9 -Inhibits PI3K/Akt/mTOR, MAPK, and NF-κB signaling pathways. -Enhances sensitivity to Chemotherapy drugs like doxorubicin and cisplatin Rutin has poor oral bioavailability, but this can be improved with nanoformulations or co-administration with absorption enhancers like piperine or quercetin. Cancer Pathway Table: Rutin
TSF: P = 0–30 min (rapid redox interactions), R = 30 min–3 hr (acute signaling shifts), G = >3 hr (gene-regulatory adaptation and phenotype outcomes).
Alzheimer’s Disease (AD) Summary — RutinRutin has been studied in preclinical neurodegeneration models for its antioxidant, anti-inflammatory, and mitochondrial-protective properties. It is reported to modulate Nrf2 signaling, suppress NF-κB–mediated neuroinflammation, reduce oxidative stress, and attenuate amyloid-β–induced neuronal injury in experimental systems. Many effects may be mediated after hydrolysis to quercetin. Human clinical evidence remains limited.Alzheimer’s Disease Table: Rutin
TSF: P = 0–30 min (early signaling modulation), R = 30 min–3 hr (stress-response shifts), G = >3 hr (gene-regulatory and neuroprotective outcomes). |
| Source: |
| Type: |
| ALOX15 - Arachidonate 15-Lipoxygenase / 15-Lipoxygenase-1 Abbreviation: ALOX15, 15-LOX, 15-LOX-1 Type: Lipoxygenase enzyme / polyunsaturated fatty-acid oxygenase Function: ALOX15 catalyzes oxygenation of arachidonic acid and other polyunsaturated fatty acids to generate bioactive lipid mediators. Important products include 15-HETE and downstream oxidized phospholipids and specialized lipid mediators. ALOX15 participates in inflammatory signaling, eosinophil biology, epithelial responses, immune-cell migration, tissue remodeling, and inflammation resolution. Asthma: ↑ ALOX15 expression and activity are increased in type-2 and eosinophilic asthma. IL-4 and IL-13 strongly induce ALOX15 in airway epithelial cells and macrophages. Increased ALOX15-derived lipid mediators promote eosinophil recruitment, goblet-cell differentiation, MUC5AC expression, epithelial inflammation, airway remodeling, and airway hyperresponsiveness. Favorable Direction in Asthma: ↓ Excess ALOX15 activity is generally favorable when the measured effect reflects suppression of type-2/eosinophilic airway inflammation, although some ALOX15-derived lipids also participate in inflammation resolution. Cancer: ↕ Context-dependent. ALOX15 can have tumor-promoting or tumor-suppressive effects depending on tissue and lipid products generated. In colorectal cancer, reduced ALOX15 and loss of pro-resolving lipid signaling have been associated with inflammation-driven tumor progression, whereas other ALOX15-derived metabolites may promote malignant signaling in selected cancers. |
| 7951- | RT, | BuckWS, | The anticancer potential of the dietary polyphenol rutin: Current status, challenges, and perspectives |
| - | Review, | Nor, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:143 Target#:1744 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid